{"id":7375,"date":"2025-04-10T09:06:22","date_gmt":"2025-04-10T09:06:22","guid":{"rendered":"https:\/\/tst.incliva.es\/?page_id=7375"},"modified":"2025-04-10T09:06:22","modified_gmt":"2025-04-10T09:06:22","slug":"research-group-on-inflammation","status":"publish","type":"page","link":"https:\/\/tst.incliva.es\/en\/que-hacemos\/areas\/metabolismo-y-dano-organico\/research-group-on-inflammation\/","title":{"rendered":"Research Group on Inflammation"},"content":{"rendered":"

\n
\n

Research Group on Inflammation<\/h3>\n<\/div>\n
<\/div><\/div>\n
Metabolism and Organic Damage Area<\/span><\/h5>\n<\/div>\n
<\/div><\/div>\n
\n
\n Study of intracellular mucin MUC1 in lung fibrosis <\/p>\n

Study of the anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist \/beta2-adrenoceptor agonist (MABA) in COPD patients <\/p>\n

Study of MUC1 deficiency in corticosteroid insensitivity in asthma <\/p>\n

Study of the systemic inflammation associated to Primary Hypercholesterolemia and Metabolic Syndrome <\/p>\n

Study of the CCL11\/CCR3 axis in Primary Hypercholesterolemia and aterosclerosis <\/p>\n

Study of the impact of PCSK9 blockade in the systemic inflammation associated to Familial Hypercholesterolemia <\/p>\n

Synthesis of new dual PPAR\u03b1\/\u03b3 agonists and pharmacology study in ob\/ob mice <\/p>\n

Synthesis of new dual LXR\/PPAR\u03b1\/\u03b3 agonists and pharmacology study
\n\n<\/div>\n<\/div>\n<\/div><\/div>